|
VCL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.551400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.190200E-01 |
| Normal-vs-Stage2 |
7.180200E-01 |
| Normal-vs-Stage3 |
1.921180E-01 |
| Normal-vs-Stage4 |
2.536600E-01 |
| Stage1-vs-Stage2 |
1.181390E-01 |
| Stage1-vs-Stage3 |
3.077800E-01 |
| Stage1-vs-Stage4 |
4.808400E-01 |
| Stage2-vs-Stage3 |
4.117800E-02 |
| Stage2-vs-Stage4 |
5.876000E-02 |
| Stage3-vs-Stage4 |
8.257000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.585200E-01 |
| Normal-vs-AfricanAmerican |
6.027600E-02 |
| Normal-vs-Asian |
2.251400E-01 |
| Caucasian-vs-AfricanAmerican |
3.395500E-02 |
| Caucasian-vs-Asian |
4.858000E-01 |
| AfricanAmerican-vs-Asian |
2.096000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.227400E-01 |
| Normal-vs-Female |
2.890800E-01 |
| Male-vs-Female |
2.968400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.670000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.547000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.291000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.162200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.828000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.410800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.727200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.104400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.487800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.446800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.921200E-01 |
| Classical-VS-Follicular |
2.15679999970853E-07 |
| Classical-VS-Other |
1.882750E-01 |
| Classical-VS-Normal |
8.794100E-02 |
| Tall-VS-Follicular |
9.619600E-04 |
| Tall-VS-Other |
1.285030E-01 |
| Tall-VS-Normal |
9.372000E-02 |
| Follicular-VS-Other |
7.021200E-01 |
| Follicular-VS-Normal |
2.516800E-01 |
| Other-VS-Normal |
8.243600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.115600E-01 |
| Normal-vs-N1 |
3.722600E-01 |
| N0-vs-N1 |
1.507430E-01 |
|
|
